David S. Knopman
Researcher Next ID · RN-023350
Researcher · Medicine
Rochester, United States
- Works count
- 2,053
- Citation count
- 173,357
- H-index
- 188
- i10-index
- 1,023
Research interests
Publications
Temporal order of clinical and biomarker changes in familial frontotemporal dementia
Nature Medicine · 2022 · https://doi.org/10.1038/s41591-022-01942-9
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Nature Communications · 2022 · https://doi.org/10.1038/s41467-022-34129-4
Alzheimer disease
Nature Reviews Disease Primers · 2021 · https://doi.org/10.1038/s41572-021-00269-y
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration
Neurology · 2021 · https://doi.org/10.1212/wnl.0000000000011848
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology
Scientific Reports · 2020 · https://doi.org/10.1038/s41598-020-59669-x
Cerebral small vessel disease genomics and its implications across the lifespan
Nature Communications · 2020 · https://doi.org/10.1038/s41467-020-19111-2
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
Nature Communications · 2020 · https://doi.org/10.1038/s41467-019-14159-1
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
Nature Communications · 2020 · https://doi.org/10.1038/s41467-020-15701-2
The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
Nature Communications · 2019 · https://doi.org/10.1038/s41467-019-09564-5
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
The Lancet Neurology · 2019 · https://doi.org/10.1016/s1474-4422(19)30394-1
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD
Acta Neuropathologica · 2019 · https://doi.org/10.1007/s00401-019-01962-9
Plasma and CSF neurofilament light
Neurology · 2019 · https://doi.org/10.1212/wnl.0000000000007767
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Acta Neuropathologica · 2019 · https://doi.org/10.1007/s00401-019-02026-8
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images
Scientific Reports · 2018 · https://doi.org/10.1038/s41598-018-22871-z
Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
JAMA · 2017 · https://doi.org/10.1001/jama.2017.3090
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
Nature Communications · 2016 · https://doi.org/10.1038/ncomms13249
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Nature Communications · 2016 · https://doi.org/10.1038/ncomms11934
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Alzheimer s & Dementia · 2016 · 10.1016/j.jalz.2016.08.005
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Neurology · 2016 · https://doi.org/10.1212/wnl.0000000000002923
PART, a distinct tauopathy, different from classical sporadic Alzheimer disease
Acta Neuropathologica · 2015 · https://doi.org/10.1007/s00401-015-1407-2
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
Nature Communications · 2015 · https://doi.org/10.1038/ncomms7760
Primary age-related tauopathy (PART): a common pathology associated with human aging
Acta Neuropathologica · 2014 · 10.1007/s00401-014-1349-0
Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial
The Lancet Neurology · 2013 · https://doi.org/10.1016/s1474-4422(12)70320-4
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
The Lancet Neurology · 2013 · 10.1016/s1474-4422(12)70291-0
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Neuron · 2011 · https://doi.org/10.1016/j.neuron.2011.09.011
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Brain · 2011 · https://doi.org/10.1093/brain/awr179
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Alzheimer s & Dementia · 2011 · https://doi.org/10.1016/j.jalz.2011.03.005
Classification of primary progressive aphasia and its variants
Neurology · 2011 · https://doi.org/10.1212/wnl.0b013e31821103e6
Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Alzheimer s & Dementia · 2011 · 10.1016/j.jalz.2011.03.004
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
The Lancet Neurology · 2009 · https://doi.org/10.1016/s1474-4422(09)70299-6
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
Brain · 2009 · 10.1093/brain/awp062
Mild Cognitive Impairment
Archives of Neurology · 2009 · 10.1001/archneurol.2009.266
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
Brain · 2008 · 10.1093/brain/awm336
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD
Neurology · 2004 · 10.1212/01.wnl.0000110315.26026.ef
Practice parameter: Diagnosis of dementia (an evidence-based review)
Neurology · 2001 · 10.1212/wnl.56.9.1143
Current projects
No projects listed.